Skip to main content
Biomarker Research logoLink to Biomarker Research
. 2023 Jul 21;11:72. doi: 10.1186/s40364-023-00512-6

Correction: Oncofetal protein IGF2BPs in human cancer: functions, mechanisms and therapeutic potential

Tian-Yu Zhu 1,2,3,4, Lian-Lian Hong 1, Zhi-Qiang Ling 1,2,3,
PMCID: PMC10362556  PMID: 37480096

Biomarker Research (2023) 11:62

10.1186/s40364-023-00499-0

The original article [1] mistakenly omitted the following Funding information:

Funding:

This work was funded by National Natural Science Foundation of China (81,972,908, 32,271,238), National Health Commission Science Research Fund-Zhejiang Provincial Health Key Science and Technology Plan Project (WKJ-ZJ-2117), Leading Talents in Scientific and Technological Innovation from Zhejiang Provincial Ten Thousand Talents Plan (Zhejiang Provincial CPC Committee Talents [2019]-3), Zhejiang Province Health Leader Talent (Zjwjw2021-40), and Major Training Personnel from Zhejiang Provincial Program for Training and Development Project for 151 Talents (Zjhrss2014-150).

Footnotes

The online version of the original article can be found at 10.1186/s40364-023-00499-0.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Zhu, TY., Hong, LL. & Ling, ZQ. Oncofetal protein IGF2BPs in human cancer: functions, mechanisms and therapeutic potential. Biomark Res 11, 62 (2023). 10.1186/s40364-023-00499-0 [DOI] [PMC free article] [PubMed]

Articles from Biomarker Research are provided here courtesy of BMC

RESOURCES